1. Bacteriocin nanoconjugates: boon to medical and food industry.
- Author
-
Sulthana, R. and Archer, A.C.
- Subjects
- *
ANTIBIOTICS , *PROTEOLYTIC enzymes , *ANTIMICROBIAL peptides , *LACTIC acid bacteria , *FOOD industry , *DRUG therapy , *PROBIOTICS - Abstract
Summary: Resistance to antibiotics is an ongoing problem in the biomedical industry. Developing active, alternative drug therapies would reduce our reliance on antibiotics that induce resistance in micro‐organisms. To date, bacteriocins and antimicrobial peptides have shown a positive outcome as antibiotic substitutes and synergists apart from phage therapy, antibodies and probiotics. Bacteriocins are proteinaceous antimicrobial peptides synthesized by lactic acid bacteria extensively used as bio‐preservatives and alternative to traditional antibiotics to overcome the problem of drug‐resistant pathogens. Nonetheless, the use of bacteriocins has several limitations such as limited antimicrobial spectrum, requiring high dose, sensitivity to proteolytic enzymes, etc. Nanoparticles are one of the promising area of research explored to improve antimicrobial spectrum of bacteriocins. This review therefore highlights the recent developments and research pertaining to use of nanoparticles and bacteriocin conjugates to tackle the resistance crisis as well as its applications in food industry. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF